Sepsis Alliance Symposium: Sepsis in Immunocompromised Patients

Sepsis is a leading cause of death, killing an estimated 350,000 adults each year in the U.S. Immunocompromised patients are even more likely to die from sepsis. For instance, sepsis mortality amongst cancer patients is 43-55% higher than in patients who do not have cancer. Immunocompromised patients may also present differently than patients who are not immunocompromised, due to a variable inflammatory response, leading to potential delays in diagnosis and treatment. This creates additional complications, as the risk of mortality from sepsis increases by 4-9% for every hour treatment is delayed. It is imperative that healthcare professionals understand the unique risks that immunocompromised patients have regarding sepsis to efficiently and accurately assess and diagnose sepsis in immunocompromised patients. This live, virtual Sepsis Alliance event, will cover critical topics related to sepsis in immunocompromised patients, including a special focus on patients with cancer and patients with HIV. The key outcome of this half-day event is to establish the burden of sepsis in immunocompromised patients and improve clinical outcomes for immunocompromised patients affected by sepsis. Free continuing nursing education credits will be available!